Alek Safarian

Alek Safarian is the current CEO of ALSA Ventures. Prior to this, they were a member of the board of directors at Novotech from January 1996 to August 2017. Alek was also the head of scientific affairs at Marion Merrell Dow (now Sanofi-Aventis) from December 1990 to December 1995 and a regulatory affairs associate at Ciba-Geigy (now Novartis) from February 1988 to November 1990.

Alek Safarian has an MBA from the University of Sydney and a B.Pharm. from the same school. Alek also attended St. Benedict's Grammar School.

Some individuals on their team include Lorna Collings - CFO, Graeme Martin - CIO.